Manage treatment without previous biopsy

[mickohanlon23]

This PR Resolves CCSMCDS-7. This removes the requirement for a high grade biopsy or cytology result to be present before a cervical treatment in order for a patient to be managed by Rare Abnormality 4 (Section J) or Risk Table 5. This functionality is parameterized so that the requirement for a high grade test before a treatment can be turned off/on. A test case is added to show that a patient is able to enter Risk Table 5 without a CIN2 or CIN 3 biopsy before their treatment. More test cases are added to show that each of the Section J Rare Abnormality 4 recommendations can be reached without high grade test results before the cervical precancer treatment.

[mickohanlon23]

• Merged in main branch
• Updated ELM file and encoded ELM in FHIR Libraries
• Updated recommendation text in newly added test cases to align with recent recommendation text update.